Adam R Karpf

14PUBLICATIONS
45CO-AUTHORS
Molecular targetsMicrobial geneticsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersBiomaterials
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Dec 19, 2025
Defects in DNA damage signaling and cell cycle checkpoints in a mouse model of Rhno1 deletion.

Joonyoung Her, Adithi Santhosh, Yanira Gonzalez-Rodriguez

|Oct 29, 2025
CRISPR Targeting the 5' Regulatory Region of FOXM1 Will Also Disrupt RHNO1.

Adam R Karpf, Niphat Jirapongwattana

|Aug 06, 2024
RHNO1: at the crossroads of DNA replication stress, DNA repair, and cancer.

Niphat Jirapongwattana, Samuel F Bunting, Donald R Ronning

|May 25, 2024
PROTACs in Ovarian Cancer: Current Advancements and Future Perspectives.

Makenzie Vorderbruggen, Carlos A Velázquez-Martínez, Amarnath Natarajan

|Nov 20, 2021
Protein kinase RNA-activated controls mitotic progression and determines paclitaxel chemosensitivity through B-cell lymphoma 2 in ovarian cancer.

Ling Yin, Yongji Zeng, Renya Zeng

|Jul 02, 2021
FOXM1: A Multifunctional Oncoprotein and Emerging Therapeutic Target in Ovarian Cancer.

Cassie Liu, Carter J Barger, Adam R Karpf

Pageof 3

Frequent Collaborators

2 joint publications

Jaeyeon Kim

2 joint publications

Amarnath Natarajan

2 joint publications

Eun Young Park

2 joint publications

David L Klinkebiel